BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 23602701)

  • 1. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative.
    Chamorro ME; Wenker SD; Vota DM; Vittori DC; Nesse AB
    Biochim Biophys Acta; 2013 Aug; 1833(8):1960-8. PubMed ID: 23602701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
    Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M; Gross AW; Lodish HF
    Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
    Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.
    Brines M; Grasso G; Fiordaliso F; Sfacteria A; Ghezzi P; Fratelli M; Latini R; Xie QW; Smart J; Su-Rick CJ; Pobre E; Diaz D; Gomez D; Hand C; Coleman T; Cerami A
    Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14907-12. PubMed ID: 15456912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis.
    Chang HC; Huang DY; Wu MS; Chu CL; Tzeng SJ; Lin WW
    Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):687-696. PubMed ID: 28131718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lack of CD131 and the inhibition of Neuro-2a growth by carbamylated erythropoietin.
    Ding J; Li QY; Yu JZ; Wang X; Lu CZ; Ma CG; Xiao BG
    Cell Biol Toxicol; 2015 Feb; 31(1):29-38. PubMed ID: 25656842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons.
    Ding J; Wang J; Li QY; Yu JZ; Ma CG; Wang X; Lu CZ; Xiao BG
    Mol Neurobiol; 2017 Sep; 54(7):5051-5060. PubMed ID: 27541284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamylated erythropoietin ameliorates cyclosporine nephropathy without stimulating erythropoiesis.
    Abe T; Isaka Y; Imamura R; Kakuta Y; Okumi M; Yazawa K; Ichimaru N; Tsuda H; Nonomura N; Takahara S; Okuyama A
    Cell Transplant; 2012; 21(2-3):571-80. PubMed ID: 22410315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
    Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamylated erythropoietin ameliorates hypoxia-induced cognitive and behavioral defects with the generation of choline acetyltransferase-positive neurons.
    Ding J; Li QY; Yu JZ; Wang X; Lu CZ; Ma CG; Xiao BG
    J Neurosci Res; 2013 Jan; 91(1):73-82. PubMed ID: 23074165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
    Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells.
    Wang L; Zhang ZG; Gregg SR; Zhang RL; Jiao Z; LeTourneau Y; Liu X; Feng Y; Gerwien J; Torup L; Leist M; Noguchi CT; Chen ZY; Chopp M
    J Biol Chem; 2007 Nov; 282(44):32462-70. PubMed ID: 17804404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.
    Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR
    Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EpoR Activation Stimulates Erythroid Precursor Proliferation by Inducing Phosphorylation of Tyrosine-88 of the CDK-Inhibitor p27
    Pegka F; Ben-Califa N; Neumann D; Jäkel H; Hengst L
    Cells; 2023 Jun; 12(13):. PubMed ID: 37443738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
    Bose C; Udupa KB
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamylated erythropoietin promotes neurite outgrowth and neuronal spine formation in association with CBP/p300.
    Choi M; Ko SY; Lee IY; Wang SE; Lee SH; Oh DH; Kim YS; Son H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):79-84. PubMed ID: 24607903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties.
    Moon C; Krawczyk M; Paik D; Coleman T; Brines M; Juhaszova M; Sollott SJ; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2006 Mar; 316(3):999-1005. PubMed ID: 16306273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEPO (carbamylated erythropoietin)-Fc protects hippocampal cells in culture against beta amyloid-induced apoptosis: considering Akt/GSK-3β and ERK signaling pathways.
    Hooshmandi E; Moosavi M; Katinger H; Sardab S; Ghasemi R; Maghsoudi N
    Mol Biol Rep; 2020 Mar; 47(3):2097-2108. PubMed ID: 32067159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.